HEADER HYDROLASE 03-APR-25 9O27 TITLE HEPARANASE P6 IN COMPLEX WITH FRAGMENT J56 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARANASE 50 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEPARANASE 8 KDA SUBUNIT; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HEPARANASE, SMALL MOLECULE, CANCER, COMPLEX, THERAPEUTICS, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.J.DAVIES,R.L.FRKIC,C.J.JACKSON REVDAT 1 11-FEB-26 9O27 0 JRNL AUTH L.J.DAVIES,C.WHITEFIELD,H.KIM,C.NITSCHE,C.J.JACKSON, JRNL AUTH 2 R.L.FRKIC JRNL TITL FRAGMENT SCREENING AND STRUCTURE-GUIDED DEVELOPMENT OF JRNL TITL 2 HEPARANASE INHIBITORS REVEAL ORTHOSTERIC AND ALLOSTERIC JRNL TITL 3 INHIBITION JRNL REF ACS MED.CHEM.LETT. 2026 JRNL REFN ISSN 1948-5875 JRNL DOI 10.1021/ACSMEDCHEMLETT.5C00587 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.21.2_5419: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 31756 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 1558 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.4000 - 4.6700 1.00 2946 157 0.1678 0.1776 REMARK 3 2 4.6700 - 3.7100 1.00 2786 153 0.1446 0.1955 REMARK 3 3 3.7100 - 3.2400 1.00 2783 148 0.1593 0.2026 REMARK 3 4 3.2400 - 2.9400 1.00 2749 136 0.1889 0.2501 REMARK 3 5 2.9400 - 2.7300 1.00 2768 134 0.1927 0.2156 REMARK 3 6 2.7300 - 2.5700 1.00 2742 143 0.1900 0.2547 REMARK 3 7 2.5700 - 2.4400 1.00 2714 154 0.1986 0.2711 REMARK 3 8 2.4400 - 2.3400 1.00 2742 142 0.2144 0.2497 REMARK 3 9 2.3400 - 2.2500 1.00 2715 108 0.2306 0.2587 REMARK 3 10 2.2500 - 2.1700 0.94 2555 139 0.2966 0.3389 REMARK 3 11 2.1700 - 2.1000 1.00 2698 144 0.2827 0.3142 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 NULL REMARK 3 ANGLE : 0.923 NULL REMARK 3 CHIRALITY : 0.052 554 REMARK 3 PLANARITY : 0.007 645 REMARK 3 DIHEDRAL : 16.597 1371 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9O27 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-APR-25. REMARK 100 THE DEPOSITION ID IS D_1000294136. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-AUG-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32012 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 47.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.60 REMARK 200 R MERGE (I) : 0.43300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : 6.75900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1 M REMARK 280 AMMONIUMA ACETATE, 25% PEG 4000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.20550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.74050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.98950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.74050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.20550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.98950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -78.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 272 -98.56 53.07 REMARK 500 LYS A 274 37.87 80.27 REMARK 500 THR A 333 -47.13 -130.63 REMARK 500 GLU A 343 118.36 -166.39 REMARK 500 LEU A 355 -53.70 -140.36 REMARK 500 LEU A 419 -163.74 -108.58 REMARK 500 ASP A 427 70.96 -158.48 REMARK 500 REMARK 500 REMARK: NULL DBREF 9O27 A 160 542 UNP Q9Y251 HPSE_HUMAN 160 542 DBREF 9O27 B 36 109 UNP Q9Y251 HPSE_HUMAN 36 109 SEQADV 9O27 LYS A 178 UNP Q9Y251 ASN 178 CONFLICT SEQADV 9O27 SER A 195 UNP Q9Y251 ALA 195 CONFLICT SEQADV 9O27 GLY A 197 UNP Q9Y251 LEU 197 CONFLICT SEQADV 9O27 ALA A 212 UNP Q9Y251 SER 212 CONFLICT SEQADV 9O27 ASP A 219 UNP Q9Y251 SER 219 CONFLICT SEQADV 9O27 ARG A 230 UNP Q9Y251 LEU 230 CONFLICT SEQADV 9O27 GLY A 234 UNP Q9Y251 ASP 234 CONFLICT SEQADV 9O27 LYS A 244 UNP Q9Y251 GLU 244 CONFLICT SEQADV 9O27 HIS A 248 UNP Q9Y251 GLN 248 CONFLICT SEQADV 9O27 GLY A 273 UNP Q9Y251 ARG 273 CONFLICT SEQADV 9O27 ALA A 292 UNP Q9Y251 SER 292 CONFLICT SEQADV 9O27 LEU A 307 UNP Q9Y251 LYS 307 CONFLICT SEQADV 9O27 THR A 318 UNP Q9Y251 ILE 318 CONFLICT SEQADV 9O27 GLN A 322 UNP Q9Y251 SER 322 CONFLICT SEQADV 9O27 LEU A 327 UNP Q9Y251 PHE 327 CONFLICT SEQADV 9O27 GLY A 354 UNP Q9Y251 LEU 354 CONFLICT SEQADV 9O27 GLN A 426 UNP Q9Y251 SER 426 CONFLICT SEQADV 9O27 ASP A 427 UNP Q9Y251 LYS 427 CONFLICT SEQADV 9O27 GLN A 477 UNP Q9Y251 LYS 477 CONFLICT SEQADV 9O27 HIS A 483 UNP Q9Y251 LEU 483 CONFLICT SEQADV 9O27 ASP A 486 UNP Q9Y251 HIS 486 CONFLICT SEQADV 9O27 GLN A 498 UNP Q9Y251 LEU 498 CONFLICT SEQADV 9O27 LYS A 512 UNP Q9Y251 MET 512 CONFLICT SEQADV 9O27 PRO A 513 UNP Q9Y251 GLU 513 CONFLICT SEQADV 9O27 ALA A 530 UNP Q9Y251 SER 530 CONFLICT SEQADV 9O27 PRO A 540 UNP Q9Y251 ALA 540 CONFLICT SEQRES 1 A 383 PHE LYS ASN SER THR TYR SER ARG SER SER VAL ASP VAL SEQRES 2 A 383 LEU TYR THR PHE ALA LYS CYS SER GLY LEU ASP LEU ILE SEQRES 3 A 383 PHE GLY LEU ASN ALA LEU LEU ARG THR SER ASP GLY GLN SEQRES 4 A 383 TRP ASN SER SER ASN ALA GLN LEU LEU LEU ASP TYR CYS SEQRES 5 A 383 ALA SER LYS GLY TYR ASN ILE ASP TRP GLU LEU GLY ASN SEQRES 6 A 383 GLU PRO ASN SER PHE ARG LYS LYS ALA GLY ILE PHE ILE SEQRES 7 A 383 ASN GLY SER GLN LEU GLY LYS ASP PHE ILE HIS LEU HIS SEQRES 8 A 383 LYS LEU LEU ARG LYS SER THR PHE LYS ASN ALA LYS LEU SEQRES 9 A 383 TYR GLY PRO ASP VAL GLY GLN PRO ARG GLY LYS THR ALA SEQRES 10 A 383 LYS MET LEU LYS SER PHE LEU LYS ALA GLY GLY GLU VAL SEQRES 11 A 383 ILE ASP ALA VAL THR TRP HIS HIS TYR TYR LEU ASN GLY SEQRES 12 A 383 ARG THR ALA THR LEU GLU ASP PHE LEU ASN PRO ASP VAL SEQRES 13 A 383 LEU ASP THR PHE ILE SER GLN VAL GLN LYS VAL LEU GLN SEQRES 14 A 383 VAL VAL GLU SER THR ARG PRO GLY LYS LYS VAL TRP LEU SEQRES 15 A 383 GLY GLU THR SER SER ALA TYR GLY GLY GLY ALA PRO GLY SEQRES 16 A 383 LEU SER ASP THR PHE ALA ALA GLY PHE MET TRP LEU ASP SEQRES 17 A 383 LYS LEU GLY LEU SER ALA ARG MET GLY ILE GLU VAL VAL SEQRES 18 A 383 MET ARG GLN VAL PHE PHE GLY ALA GLY ASN TYR HIS LEU SEQRES 19 A 383 VAL ASP GLU ASN PHE ASP PRO LEU PRO ASP TYR TRP LEU SEQRES 20 A 383 SER LEU LEU PHE LYS LYS LEU VAL GLY THR LYS VAL LEU SEQRES 21 A 383 MET ALA SER VAL GLN GLY GLN ASP ARG ARG LYS LEU ARG SEQRES 22 A 383 VAL TYR LEU HIS CYS THR ASN THR ASP ASN PRO ARG TYR SEQRES 23 A 383 LYS GLU GLY ASP LEU THR LEU TYR ALA ILE ASN LEU HIS SEQRES 24 A 383 ASN VAL THR LYS TYR LEU ARG LEU PRO TYR PRO PHE SER SEQRES 25 A 383 ASN LYS GLN VAL ASP GLN TYR LEU LEU ARG PRO HIS GLY SEQRES 26 A 383 PRO ASP GLY LEU LEU SER LYS SER VAL GLN LEU ASN GLY SEQRES 27 A 383 GLN THR LEU LYS MET VAL ASP ASP GLN THR LEU PRO PRO SEQRES 28 A 383 LEU LYS PRO LYS PRO LEU ARG PRO GLY SER SER LEU GLY SEQRES 29 A 383 LEU PRO ALA PHE SER TYR ALA PHE PHE VAL ILE ARG ASN SEQRES 30 A 383 ALA LYS VAL PRO ALA CYS SEQRES 1 B 74 GLN ASP VAL VAL ASP LEU ASP PHE PHE THR GLN GLU PRO SEQRES 2 B 74 LEU HIS LEU VAL SER PRO SER PHE LEU SER VAL THR ILE SEQRES 3 B 74 ASP ALA ASN LEU ALA THR ASP PRO ARG PHE LEU ILE LEU SEQRES 4 B 74 LEU GLY SER PRO LYS LEU ARG THR LEU ALA ARG GLY LEU SEQRES 5 B 74 SER PRO ALA TYR LEU ARG PHE GLY GLY THR LYS THR ASP SEQRES 6 B 74 PHE LEU ILE PHE ASP PRO LYS LYS GLU HET EDO A 601 4 HET ACT A 602 4 HET 8KB A 603 8 HET SO4 A 604 5 HET SO4 A 605 5 HETNAM EDO 1,2-ETHANEDIOL HETNAM ACT ACETATE ION HETNAM 8KB (6~{R})-1,4-OXAZEPAN-6-OL HETNAM SO4 SULFATE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO C2 H6 O2 FORMUL 4 ACT C2 H3 O2 1- FORMUL 5 8KB C5 H11 N O2 FORMUL 6 SO4 2(O4 S 2-) FORMUL 8 HOH *207(H2 O) HELIX 1 AA1 SER A 166 SER A 180 1 15 HELIX 2 AA2 SER A 201 LYS A 214 1 14 HELIX 3 AA3 GLU A 225 ASN A 227 5 3 HELIX 4 AA4 SER A 228 GLY A 234 1 7 HELIX 5 AA5 ASN A 238 SER A 256 1 19 HELIX 6 AA6 THR A 275 GLY A 287 1 13 HELIX 7 AA7 THR A 306 LEU A 311 1 6 HELIX 8 AA8 ASN A 312 SER A 332 1 21 HELIX 9 AA9 THR A 358 ALA A 360 5 3 HELIX 10 AB1 ALA A 361 GLY A 376 1 16 HELIX 11 AB2 LEU A 401 LEU A 413 1 13 HELIX 12 AB3 PRO A 469 LYS A 473 5 5 HELIX 13 AB4 ASP A 486 SER A 490 5 5 HELIX 14 AB5 ASN B 64 ASP B 68 5 5 HELIX 15 AB6 ARG B 70 GLY B 76 1 7 HELIX 16 AB7 SER B 77 LEU B 87 1 11 HELIX 17 AB8 GLY B 96 ASP B 100 5 5 SHEET 1 AA1 2 SER A 163 TYR A 165 0 SHEET 2 AA1 2 LEU B 102 PHE B 104 1 O ILE B 103 N SER A 163 SHEET 1 AA2 9 LEU A 182 LEU A 188 0 SHEET 2 AA2 9 ASP A 219 LEU A 222 1 O GLU A 221 N LEU A 188 SHEET 3 AA2 9 LEU A 263 VAL A 268 1 O TYR A 264 N TRP A 220 SHEET 4 AA2 9 ALA A 292 ASN A 301 1 O HIS A 296 N VAL A 268 SHEET 5 AA2 9 VAL A 339 TYR A 348 1 O TRP A 340 N VAL A 293 SHEET 6 AA2 9 ILE A 377 ARG A 382 1 O MET A 381 N LEU A 341 SHEET 7 AA2 9 LEU B 57 ASP B 62 1 O SER B 58 N VAL A 380 SHEET 8 AA2 9 ALA B 90 GLY B 95 1 O ARG B 93 N ILE B 61 SHEET 9 AA2 9 LEU A 182 LEU A 188 1 N ILE A 185 O PHE B 94 SHEET 1 AA3 4 GLN A 498 THR A 499 0 SHEET 2 AA3 4 VAL A 493 LEU A 495 -1 N LEU A 495 O GLN A 498 SHEET 3 AA3 4 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA3 4 LYS A 514 PRO A 515 -1 O LYS A 514 N GLN A 477 SHEET 1 AA4 8 GLN A 498 THR A 499 0 SHEET 2 AA4 8 VAL A 493 LEU A 495 -1 N LEU A 495 O GLN A 498 SHEET 3 AA4 8 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA4 8 SER A 528 ILE A 534 -1 O PHE A 531 N TYR A 478 SHEET 5 AA4 8 LEU A 450 ASN A 456 -1 N LEU A 452 O PHE A 532 SHEET 6 AA4 8 LEU A 431 THR A 438 -1 N HIS A 436 O THR A 451 SHEET 7 AA4 8 VAL A 414 VAL A 418 -1 N GLY A 415 O CYS A 437 SHEET 8 AA4 8 HIS B 50 LEU B 51 -1 O HIS B 50 N VAL A 418 SHEET 1 AA5 4 MET A 420 VAL A 423 0 SHEET 2 AA5 4 VAL B 38 PHE B 44 -1 O PHE B 44 N MET A 420 SHEET 3 AA5 4 LYS A 462 ARG A 465 1 N TYR A 463 O VAL B 39 SHEET 4 AA5 4 LEU A 522 LEU A 524 -1 O LEU A 522 N LEU A 464 SSBOND 1 CYS A 437 CYS A 542 1555 1555 2.04 CISPEP 1 GLY A 265 PRO A 266 0 6.68 CISPEP 2 GLN A 383 VAL A 384 0 -6.06 CISPEP 3 TYR A 468 PRO A 469 0 3.96 CISPEP 4 SER B 88 PRO B 89 0 -3.19 CRYST1 58.411 73.979 123.481 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017120 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013517 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008098 0.00000 CONECT 2193 3025 CONECT 3025 2193 CONECT 3622 3623 3624 CONECT 3623 3622 CONECT 3624 3622 3625 CONECT 3625 3624 CONECT 3626 3627 3628 3629 CONECT 3627 3626 CONECT 3628 3626 CONECT 3629 3626 CONECT 3630 3632 3633 CONECT 3631 3632 CONECT 3632 3630 3631 3637 CONECT 3633 3630 3634 CONECT 3634 3633 3635 CONECT 3635 3634 3636 CONECT 3636 3635 3637 CONECT 3637 3632 3636 CONECT 3638 3639 3640 3641 3642 CONECT 3639 3638 CONECT 3640 3638 CONECT 3641 3638 CONECT 3642 3638 CONECT 3643 3644 3645 3646 3647 CONECT 3644 3643 CONECT 3645 3643 CONECT 3646 3643 CONECT 3647 3643 MASTER 227 0 5 17 27 0 0 6 3844 2 28 36 END